Abstract:Objective To evaluate the therapeutic effects of vitamin E(Vit E)on the AIMS scores in schizophrenic patients with tar-dive dyskinesia(TD)and possible therapeutic mechanisms. Methods Eligible patients(n =80)would be randomized to receive vitamin E (1 200U/ d)or placebo. The present study would be double blinded and last for 12 weeks. The symptoms of TD and psychopathology were as-sessed by using Abnormal Involuntary Movement Scale(AIMS)and Positive and Negative Symptoms Scale(PANSS)respectively,the plasma superoxide dismutase(SOD),catalase(CAT),glutathione peroxidase(GSH - Px)activities and maleicdialdehyde(MDA)levels were assayed. Results ①Vit E could be markedly effective in reducing the severities of dyskinesia in patients of TD,but the placebo could not improve the AIMS scores. ②The Vit E might increase the activities of SOD[baseline(85. 8 ±18. 3)U/ ml,after treatment(101. 5 ±25. 1)U/ ml], CAT[baseline(1.8 ±1.1)U/ ml,after treatment(3.1 ±2.1)U/ ml],GSH - Px[ baseline(106.8 ±28.3)U/ ml,after treatment(133.1 ± 31.0)U/ ml]and decrease the levels of MDA[baseline(13.2 ±6. 7)nmol/ ml,after treatmDent(8. 6 ± 5. 5)nmol/ ml]significantly(P <0.05),however,the placebo could not effect on the biochemistry measures. Conclusion Vit E is markedly effective on reducing the severity of dyskinesia in TD,and oxidative damages might be key pathophysiological factor of TD.

Treatment of vitamin E on the patients with tardive dyskinesia and possible mechanisms